+

PE20001468A1 - Compuestos no peptidicos como secretagogos de la hormona del crecimiento - Google Patents

Compuestos no peptidicos como secretagogos de la hormona del crecimiento

Info

Publication number
PE20001468A1
PE20001468A1 PE2000000127A PE0001272000A PE20001468A1 PE 20001468 A1 PE20001468 A1 PE 20001468A1 PE 2000000127 A PE2000000127 A PE 2000000127A PE 0001272000 A PE0001272000 A PE 0001272000A PE 20001468 A1 PE20001468 A1 PE 20001468A1
Authority
PE
Peru
Prior art keywords
growth hormone
secretagogs
peptidic compounds
refers
phenyl
Prior art date
Application number
PE2000000127A
Other languages
English (en)
Inventor
Jeffrey Alan Dodge
Iii Charles Willis Lugar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20001468A1 publication Critical patent/PE20001468A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN COMPUESTO NO PEPTIDICOS DE FORMULA I DONDE R1 ES C6H5CH2OCH2-, C6H5(CH2)3-, INDOL-3-ILMETILO; Y ES PIRROLIDINILO, 4-METILPIPERIDINILO, NR2R2; R2 ES ALQUILO C1-C6; R3 ES 2-NAFTILO, FENILO SUSTITUIDO CON W; W ES H, F, CF3, ALCOXI C1-C6, FENILO; R4 ES H, CH3. SE REFIERE TAMBIEN A UNA FORMULACION ADEMAS CONTIENE UN AGENTE DE ANTIREABSORCION OSEA TAL COMO BISFOSFONATO. LOS COMPUESTOS NO PEPTIDICOS TIENEN ACTIVIDAD COMO SECRETAGOGOS DE LA HORMONA DE CRECIMIENTO POR LO QUE PUEDEN SER UTIL PARA EL TRATAMIENTO DE LA DEFICIENCIAS EN HORMONA DEL CRECIMIENTO EN VACAS, OVEJAS, AVES DE CORRAL
PE2000000127A 1999-02-19 2000-02-18 Compuestos no peptidicos como secretagogos de la hormona del crecimiento PE20001468A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12081399P 1999-02-19 1999-02-19

Publications (1)

Publication Number Publication Date
PE20001468A1 true PE20001468A1 (es) 2000-12-20

Family

ID=22392709

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000127A PE20001468A1 (es) 1999-02-19 2000-02-18 Compuestos no peptidicos como secretagogos de la hormona del crecimiento

Country Status (13)

Country Link
EP (1) EP1153034B1 (es)
JP (1) JP2002539089A (es)
CN (1) CN1179972C (es)
AR (1) AR023369A1 (es)
AT (1) ATE375996T1 (es)
AU (1) AU765642B2 (es)
BR (1) BR0008321A (es)
CA (1) CA2362303A1 (es)
CO (1) CO5160260A1 (es)
DE (1) DE60036785D1 (es)
IL (1) IL144350A0 (es)
PE (1) PE20001468A1 (es)
WO (1) WO2000049037A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
WO2001091752A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
GT200100147A (es) * 2000-07-31 2002-06-25 Derivados de imidazol
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives
US20040106665A1 (en) * 2000-10-13 2004-06-03 Kress Thomas Joseph Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methodxyphenylpropionic acid and salts thereof
DE60111574T2 (de) * 2001-01-23 2006-05-11 Gador S.A. Bisphosphonate enthaltende Zusammensetzungen zur Vorbeugung und/oder Heilung von metabolischen Knochenkrankheiten, Verfahren zu ihrer Herstellung und Benutzung dieser Zusammensetzungen
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
ES2266798T3 (es) * 2002-04-09 2007-03-01 Eli Lilly And Company Secretagodos de hormona de crecimiento.
ATE399155T1 (de) 2004-03-23 2008-07-15 Pfizer Prod Inc Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
AU2006293619A1 (en) 2005-09-22 2007-03-29 Pfizer Products Inc. Imidazole compounds for the treatment of neurological disorders
US10590087B1 (en) 2019-08-09 2020-03-17 Pfizer Inc. Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
US11884634B2 (en) 2019-08-09 2024-01-30 Pfizer Inc. Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide
EP4396159A1 (en) 2021-09-01 2024-07-10 Springworks Therapeutics, Inc. Synthesis of nirogacestat
US11504354B1 (en) 2021-09-08 2022-11-22 SpringWorks Therapeutics Inc.. Chlorinated tetralin compounds and pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107836A (en) * 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
NZ258412A (en) * 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
WO1998016527A1 (en) * 1996-10-15 1998-04-23 Fujisawa Pharmaceutical Co., Ltd. Benzoxepine derivatives which promote release of growth hormone
ZA987385B (en) * 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.

Also Published As

Publication number Publication date
CN1179972C (zh) 2004-12-15
AU765642B2 (en) 2003-09-25
CO5160260A1 (es) 2002-05-30
AU3496800A (en) 2000-09-04
EP1153034B1 (en) 2007-10-17
EP1153034A1 (en) 2001-11-14
WO2000049037A1 (en) 2000-08-24
CN1347420A (zh) 2002-05-01
IL144350A0 (en) 2002-05-23
CA2362303A1 (en) 2000-08-24
AR023369A1 (es) 2002-09-04
DE60036785D1 (de) 2007-11-29
JP2002539089A (ja) 2002-11-19
BR0008321A (pt) 2002-01-29
ATE375996T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
PE20001468A1 (es) Compuestos no peptidicos como secretagogos de la hormona del crecimiento
ATE211466T1 (de) Depsipeptide, herstellung und anwendung
BR0215517A (pt) Composição anti-séptica, e, métodos para desinfetar tecido e para produzir uma composição anti-séptica
PE20010126A1 (es) Pirrolotriazinas como inhibidores de cinasas
ATE395056T1 (de) Verwendung von r-(+)-2-(3-diisopropylamino-1- phenylpropyl)-4-hydroxy-methyl- phenylisobuttersäureester hydrogenfumarat zur behandlung von harndrang-inkontinenz und anderen spasmogenen leiden
PE20020693A1 (es) Agonistas del receptor alfa activado del proliferador de peroxisomas
PE20010286A1 (es) Derivados de indoloxoacetil piperazina como agentes antivirales
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
ECSP055684A (es) Antagonistas del receptor opiode
AR031828A2 (es) Procedimientos para la preparacion de compuestos espiro-azabiciclicos utiles en terapia
AR016977A1 (es) Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos, composiciones farmaceuticas, uso, intermediarios utiles, procedimientosde preparacion
PE20020419A1 (es) Tiadiazoles y oxadiazoles como inhibidores de fosfodiesterasa-7 (pde7)
DE69231298D1 (de) Substituierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen und Anwendungsmethoden
DE50214138D1 (de) Antimikrobiell wirksame 4-methyl-4-aryl-2-pentanole, deren herstellung und verwendung
PE20241304A1 (es) Compuestos para el tratamiento del dolor, en particular el dolor neuropatico, y/u otras enfermedades o trastornos que se asocian con at2r y/o senalizacion mediada por at2r
AR017904A1 (es) Mezclas fungicidas y procedimentos para controlar hongos nocivos que las emplean.
CO5550397A2 (es) Orto-ciclopropil-tienil-carboxamidas con actividad fungicida
ES2196049T3 (es) Uso de 2-(2-alquilfenilamino)oxazolinas y -tiazolinas para la fabricacion de un medicamento con efecto alfa 2 adrenergico.
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
PE20030858A1 (es) Acidos 3-(imidazolil)-2-aminopropanoicos
BR0004143A (pt) Composição biocida estável, e, processo para estabilizar uma composição biocida
MX9307475A (es) Monofilamentos antimicrobianos para cepillos de dientes.
BR0110385A (pt) Composto, composição anti-helmìntica, acaricida ou inseticida, método de proteção de plantas ou animais de danos causados por parasitas, e, uso de um composto
PE20010582A1 (es) Antagonistas de los receptores de vitronectina
PE20001350A1 (es) Retinamidas del acido 7-aril-6(z)-heptatrienoico como inductores de la apoptosis

Legal Events

Date Code Title Description
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载